Promising results from a phase II study for people with early-stage Parkinson’s Date 8 October 2019 A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Research shows at home exercise improves movement symptoms Date 19 September 2019 Researchers have shown that those taking part in a home-based exercise programme experienced improvements in their motor symptoms.
Prostate drug shows promise in Parkinson’s Date 17 September 2019 A drug used to treat enlarged prostates may have exciting potential for slowing down Parkinson's, according to research published in the Journal of Clinical Investigation.
Hormone treatment slows Parkinson's symptoms in mice Date 20 August 2019 Researchers have shown that boosting levels of oestrogen in the brains of mice improved symptoms by slowing the build-up of the toxic protein alpha-synuclein.
New device improves Parkinson’s symptoms Date 25 July 2019 Researchers have shown that an ‘easy to use’ portable stimulation headset may be able to reduce both motor and non-motor symptoms of Parkinson’s.
New research puts serotonin at the heart of Parkinson’s Date 20 June 2019 In a seminal research paper, published in Lancet Neurology, researchers from King’s College London have used brain scans to uncover early changes in the brain that may happen years before the symptoms of Parkinson's appear.
HYPE protein found to target alpha-synuclein Date 19 June 2019 Researchers in the US have identified a protein in the brain that may reduce the spread of the toxic alpha-synuclein protein in Parkinson's.
Existing drugs may help the brain protect itself against Parkinson's Date 5 June 2019 Researchers at King's College London have investigated the properties of over 1,000 approved drugs to identify 2 with potential for Parkinson's.
New mouse model highlights promising potential drug for slowing Parkinson’s Date 4 June 2019 The results indicate that, when given early, the molecule Anle138b may restore dopamine levels and help slow or stop Parkinson’s in its tracks.
Repurposed drug enters clinical trial for Lewy body dementia Date 3 June 2019 Researchers in the US have launched a clinical trial to test a drug with the potential to slow the progression of Lewy body dementia.
